188 related articles for article (PubMed ID: 29619987)
1. Comorbidities of bullous pemphigoid in a Finnish cohort.
Pankakoski A; Sintonen H; Ranki A; Kluger N
Eur J Dermatol; 2018 Apr; 28(2):157-161. PubMed ID: 29619987
[TBL] [Abstract][Full Text] [Related]
2. The association between bullous pemphigoid and comorbidities: a case-control study in Moroccan patients.
Titou H; Kerrouch H; Frikh R; Hjira N
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):7-11. PubMed ID: 35339128
[TBL] [Abstract][Full Text] [Related]
3. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
4. Association between bullous pemphigoid and neurologic diseases: a case-control study.
Casas-de-la-Asunción E; Ruano-Ruiz J; Rodríguez-Martín AM; Vélez García-Nieto A; Moreno-Giménez JC
Actas Dermosifiliogr; 2014 Nov; 105(9):860-5. PubMed ID: 25004905
[TBL] [Abstract][Full Text] [Related]
5. Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland.
Försti AK; Jokelainen J; Timonen M; Tasanen K
Acta Derm Venereol; 2016 Aug; 96(6):758-61. PubMed ID: 26806363
[TBL] [Abstract][Full Text] [Related]
6. Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study.
Varpuluoma O; Försti AK; Jokelainen J; Turpeinen M; Timonen M; Tasanen K; Huilaja L
J Am Acad Dermatol; 2018 Dec; 79(6):1034-1038.e5. PubMed ID: 29803903
[TBL] [Abstract][Full Text] [Related]
7. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid and antecedent neurological diseases: An association with dementia.
Yu Phuan CZ; Yew YW; Tey HL
Indian J Dermatol Venereol Leprol; 2017; 83(4):457-461. PubMed ID: 28584223
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.
Baum S; Steinberg S; Tzanani I; Barzilai A; Lyakhovitsky A
Acta Derm Venereol; 2023 Mar; 103():adv00888. PubMed ID: 36916952
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.
Kibsgaard L; Rasmussen M; Lamberg A; Deleuran M; Olesen AB; Vestergaard C
Br J Dermatol; 2017 Jun; 176(6):1486-1491. PubMed ID: 28235244
[TBL] [Abstract][Full Text] [Related]
12. Bullous Pemphigoid and Malignancy in Two Different Hospital Populations: A Retrospective Cohort Review.
Wright B; Halper K; Worswick S
Oncology; 2020; 98(5):318-320. PubMed ID: 32182611
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.
Försti AK; Jokelainen J; Ansakorpi H; Seppänen A; Majamaa K; Timonen M; Tasanen K
Sci Rep; 2016 Nov; 6():37125. PubMed ID: 27845416
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital.
Försti AK; Jokelainen J; Timonen M; Tasanen K
Br J Dermatol; 2014 Nov; 171(5):1223-6. PubMed ID: 24934834
[TBL] [Abstract][Full Text] [Related]
15. Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study.
Martin E; Mauer I; Malzahn U; Heuschmann PU; Goebeler M; Benoit S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):798-805. PubMed ID: 35657083
[TBL] [Abstract][Full Text] [Related]
16. Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.
Thorslund K; Seifert O; Nilzén K; Grönhagen C
Arch Dermatol Res; 2017 Nov; 309(9):721-727. PubMed ID: 28875235
[TBL] [Abstract][Full Text] [Related]
17. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid and malignancy.
Ortíz LJ; Vázquez M; Sánchez JL
Bol Asoc Med P R; 1990 Oct; 82(10):458-9. PubMed ID: 2080959
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.
Sim B; Fook-Chong S; Phoon YW; Koh HY; Thirumoorthy T; Pang SM; Lee HY
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1709-1714. PubMed ID: 28485892
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid and internal diseases - A case-control study.
Jedlickova H; Hlubinka M; Pavlik T; Semradova V; Budinska E; Vlasin Z
Eur J Dermatol; 2010; 20(1):96-101. PubMed ID: 19797038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
